$GNMK News

Last published 5y ago

5y agoGNMKGene Panel Market size worth $ 8.22 Million, Globally, by 2028 at 21.36% CAGR: Verified Market Research®GlobeNewswireJersey City, New Jersey, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, "Gene Panel Market" By Technique (Amplicon-Based Approach, Hybridization-Based Approach), By Design (Predesigned Gene Panels, Customized Ge
5y agoSLGG GNMK STAY NBLXMoore Kuehn Encourages SLGG, GNMK, STAY, and NBLX Investors to Contact Law FirmPR NewswireMoore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
5y agoLLY AMC AAL UAL+7Stocks making the biggest moves midday: Eli Lilly, AMC, Delta Air Lines and moreCNBCCheck out the companies with notable stock price moves on Monday.
5y agoGNMK NXPI PENN GNRC+17Stocks making the biggest moves in the premarket: GenMark Diagnostics, AMC Entertainment, Eli Lilly & moreCNBCThe stocks making the biggest moves in premarket trading include GenMark Diagnostics, AMC Entertainment, Eli Lilly, and more.
5y agoGNMKRoche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sampleGlobeNewswireRoche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021GenMark provides molecular diagnostic tests that are designed to detect multiple...
5y agoGNMKNew patent application published for: Processing Cartridge and Method for Detecting a Pathogen in a SampleUS Patent Applications (USPTO)
5y agoGNMKGenMark Diagnostics Reports Fourth Quarter and Full Year 2020 ResultsGlobeNewswireCARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
5y agoGNMKGenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico AnalysisGlobeNewswireCARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
5y agoGNMKGenMark Diagnostics to Participate in the Cowen 41st Annual Health Care ConferenceGlobeNewswireCARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
5y agoGNMKStudy Highlights Potential Clinical Value of ePlex® Blood Culture ID PanelsGlobeNewswireCARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the...
5y agoGNMKGenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021GlobeNewswireCARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market...
5y agoGNMKGenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020GlobeNewswireCARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
5y agoGNMKGenMark Diagnostics to Participate in Upcoming Investor ConferencesGlobeNewswireCARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
6y agoGNMKGenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics ForumGlobeNewswireCARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
6y agoGNMKGenMark Diagnostics Reports Third Quarter 2020 ResultsGlobeNewswireCARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
6y agoGNMKNew patent granted for: InstrumentUS Patent Applications (USPTO)
6y agoGNMKNew patent granted for: Apparatus, Devices, and Methods for Manipulating Deformable Fluid VesselsUS Patent Applications (USPTO)
6y agoGNMKGenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020GlobeNewswireCARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...
6y agoGILD GNMK5 things to know before the stock market opens FridayCNBCDow futures advanced Friday as investors sought clarity around whether another round of coronavirus stimulus was still possible.
6y agoGNMK EXC NVDA ZM+1Stocks making the biggest moves after hours: GenMark Diagnostics, Nvidia, Zoom Video & moreCNBCThese are the stocks posting the largest moves after hours Thursday.
6y agoGNMKGenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDAGlobeNewswireRP2 Panel at a Glance GenMark’s ePlex® Respiratory Pathogen Panel 2 (RP2 Panel) has received Emergency Use Authorization from the FDA.The RP2 Panel provides results in less than two hours for more...
6y agoGNMKGenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020GlobeNewswireCARLSBAD, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
6y agoGNMKFDA grants emergency clearance for GenMark test that screens for the flu, coronavirus and other virusesCNBCTests that can screen for the flu, the coronavirus and other pathogens could be crucial in combating Covid-19 and influenza this winter, public health specialists say.
6y agoGNMK SINT FLDM FITInnovative Devices Help Ease the Burden of Tracking DiseasesPR NewswireAs technology evolves to increase productivity and eliminate or reduce human error, several major industries are expected to undergo significant...
6y agoMIST GNMK DRTX CBAY+1Milestone Pharmaceuticals Strengthens Board of Directors with Two New AppointmentsPR NewswireMilestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
6y agoGNMKGenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE MarkGlobeNewswireMolecular syndromic test for COVID-19, influenza and other common respiratory pathogenshelps health care professionals prepare for flu season RP2 Panel at a Glance GenMark’s ePlex® Respiratory...
6y agoGNMKGenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 TestGlobeNewswireCARLSBAD, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that it has...
6y agoANPC DGX GNMK CEMI+1Diagnostics Begin to Play a Greater Role in the Fight Against CancerPR NewswireThe diagnostics industry is highly diverse, with a vast number of testing methods already on the market and a consistent flow of new technologies. In ...
6y agoGNMKGenMark Diagnostics Reports Second Quarter 2020 ResultsGlobeNewswireCARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
6y agoGNMKGenMark Diagnostics to Participate in Upcoming Investor ConferencesGlobeNewswireCARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
6y agoGNMKGenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020GlobeNewswireCARLSBAD, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close...
6y agoREPL GNMKBiodesix Appoints Jean Franchi and Hany Massarany to Board of DirectorsBusiness WireBOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. a leader in lung cancer diagnostics, today announced the appointment of Jean Franchi and Hany Massarany to the company’s board of directors. Ms. Franchi has more than 30 years of biotechnology and life science industry experience ranging from pre-commercial to global commercial biotech operations. Mr. Massarany has extensive experience in the global ...
6y agoGNMKGenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020GlobeNewswireCARLSBAD, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
6y agoGNMKGenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)GlobeNewswireCARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that its...
6y agoGNMKGenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant HealthGlobeNewswireCARLSBAD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, has been selected by...
6y agoGNMKGenMark Prices Public Offering of Common StockGlobeNewswireCARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
6y agoGNMKGenMark Commences Public Offering of Common StockGlobeNewswireCARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
6y agoGNMKGenMark Diagnostics Reports First Quarter 2020 ResultsGlobeNewswireCARLSBAD, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. ("GenMark" or the "Company") (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing...
6y agoGNMKGenMark Diagnostics Announces Scott Mendel Appointed CEOGlobeNewswireCARLSBAD, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
6y agoDHR TMO QGEN GNMK+1Coronavirus Test Makers Outperform After Analysts Tout DevelopmentsBloombergA handful of healthcare companies that are developing or selling tests to diagnose the coronavirus traded higher on Thursday after Cowen analysts highlighted the rise in the number of tests being conducted in the U.S.
6y agoGNMKGenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020GlobeNewswireCARLSBAD, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close...
6y agoGNMKNew patent granted for: Biochip CartridgeUS Patent Applications (USPTO)
6y agoGNMKGenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue GuidanceGlobeNewswireCARLSBAD, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
6y agoGNMKGenMark Awarded BARDA Grant for the Development of ePlex® RP2 PanelGlobeNewswireCARLSBAD, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has...
6y agoGNMKGenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 TestGlobeNewswireCOVID-19 diagnosis in under two hours now available globally in hospitals on company’s ePlex System Unique sample-to-answer capability enables near patient testing for the most critical patient...
6y agoGNMKGenMark Diagnostics Announces Submission of Emergency Use Authorization for its ePlex® SARS-CoV-2 TestGlobeNewswireCARLSBAD, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
6y agoGNMKGenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q4 2019 Results - Earnings Call TranscriptEarnings Call Transcripts
6y agoGNMKGenMark Diagnostics Reports Fourth Quarter and Full Year 2019 ResultsGlobeNewswireCARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
6y agoGNMKGenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 DetectionGlobeNewswireCARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
6y agoGNMKGenMark Diagnostics to Participate in the Cowen Health Care ConferenceGlobeNewswireCARLSBAD, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...